Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report

[1] Lacy BE(2016)Bowel disorders Gastroenterology 150 1393-1407

[2] Mearin F(2009)Irritable bowel syndrome: novel views on the epidemiology and potential risk factors Dig Liver Dis. 41 772-780

[3] Chang L(2016)Population prevalence of Rome IV and Rome III Irritable Bowel Syndrome (IBS) in the United States (US), Canada and the United Kingdom (UK) Gastroenterology 150 S739-S740

[4] Rey E(2014)Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences Am J Gastroenterol 109 876-884

[5] Talley NJ(2015)Long term effects of mindfulness on quality of life in irritable bowel syndrome Iran J Psychiatry. 10 100-105

[6] Palsson OS(2016)Fundamentals of neurogastroenterology: physiology/motility—sensation Gastroenterology 150 1292-1304

[7] van Tilburg MA(2016)Management of the clinical issue of constipation with abdominal complaints in adults. A national survey of Primary Care physicians and gastroenterologists Rev Esp Enferm Dig 108 323-331

[8] Simren M(2016)Clinical Practice Guideline: irritable bowel syndrome with constipation and functional constipation in the adult Rev Esp Enferm Dig 108 332-363

[9] Sperber AD(2011)Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases Pharmacol Ther 130 71-82

[10] Whitehead WE(2010)Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit Eur J Pharmacol 649 328-335

[1] Lacy BE(2016)Bowel disorders Gastroenterology 150 1393-1407

[2] Mearin F(2009)Irritable bowel syndrome: novel views on the epidemiology and potential risk factors Dig Liver Dis. 41 772-780

[3] Chang L(2016)Population prevalence of Rome IV and Rome III Irritable Bowel Syndrome (IBS) in the United States (US), Canada and the United Kingdom (UK) Gastroenterology 150 S739-S740

[4] Rey E(2014)Chronic constipation, irritable bowel syndrome with constipation and constipation with pain/discomfort: similarities and differences Am J Gastroenterol 109 876-884

[5] Talley NJ(2015)Long term effects of mindfulness on quality of life in irritable bowel syndrome Iran J Psychiatry. 10 100-105

[6] Palsson OS(2016)Fundamentals of neurogastroenterology: physiology/motility—sensation Gastroenterology 150 1292-1304

[7] van Tilburg MA(2016)Management of the clinical issue of constipation with abdominal complaints in adults. A national survey of Primary Care physicians and gastroenterologists Rev Esp Enferm Dig 108 323-331

[8] Simren M(2016)Clinical Practice Guideline: irritable bowel syndrome with constipation and functional constipation in the adult Rev Esp Enferm Dig 108 332-363

[9] Sperber AD(2011)Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases Pharmacol Ther 130 71-82

[10] Whitehead WE(2010)Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit Eur J Pharmacol 649 328-335